全球胺基酸代谢紊乱治疗市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

预计到 2032 年，全球胺基酸代谢紊乱治疗市场的市场规模将从 2023 年的 7.1529 亿美元达到近 11.0111 亿美元，2024-2032 年研究期间的复合年增长率为 4.91%。

胺基酸代谢紊乱是遗传性代谢疾病，通常出现在儿童时期。这些疾病会影响胺基酸的代谢，例如苯酮尿症、酪胺酸血症、高胱胺酸尿症和非酮症高甘胺酸血症等。这些疾病是体染色体隐性遗传，可以透过分析体液中的胺基酸浓度来诊断。胺基酸代谢紊乱的治疗可能包括特殊饮食、药物和少量补充剂。血液检查、透析和移植是胺基酸代谢紊乱的一些治疗方法。

市场动态

未来，由于苯酮尿症和枫糖尿等氨基酸代谢紊乱的盛行率上升，全球氨基酸代谢紊乱治疗市场预计将成长。由于氨基酸补充剂成本上升和患者不依从性，氨基酸代谢紊乱治疗市场的扩张在未来几年将放缓。家族性高胆固醇血症、戈谢氏症、亨特氏症候群、克拉伯氏症、异染性脑白质营养不良、粒线体脑病变、乳酸性酸中毒、中风样发作（MELAS）和尼曼匹克病预计将成为胺基酸代谢紊乱治疗市场的重要成长动力预测期。同样，慢性病盛行率的上升需要更有效的治疗管理以改善患者的治疗效果。因此，胺基酸代谢紊乱治疗市场预计在整个预测期内显着成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球胺基酸代谢紊乱治疗市场的各个细分市场进行了包容性评估。胺基酸代谢紊乱治疗产业的成长和趋势为本研究提供了整体方法。

市场区隔

胺基酸代谢紊乱治疗市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按指示

• 精氨基琥珀学术界
• 瓜氨酸血症
• 同型胱胺酸尿症
• 苯酮尿症
• 枫糖尿病

按产品分类

• 精胺酸
• 甜菜碱
• 卡尔格酸
• 叶酸
• 沙丙蝶呤二盐酸盐
• 硫胺素
• 维生素 B6 和 B12
• 维生素D

按配销通路

• 医院药房
• 零售药局
• 网上商店

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲氨基酸代谢紊乱治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。胺基酸代谢紊乱治疗市场的主要参与者包括 Amino GmbH、Civentichem LLC、Koninklijke DSM NV、Kyowa Hakko Kirin Co. Ltd、Merck KGaA 和 Recordati SPA 本节包含竞争格局的整体视图，包括各种策略发展例如关键併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：胺基酸代谢紊乱治疗 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按指标进行的市场吸引力分析
  • 按产品分類的市场吸引力分析
  • 按配销通路分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球胺基酸代谢紊乱治疗市场分析：依适应症分类

• 按指示概述
• 按指示进行历史和预测资料分析
• 精氨基琥珀学术界
• 瓜氨酸血症
• 同型胱胺酸尿症
• 苯酮尿症
• 枫糖尿病

第 6 章：全球胺基酸代谢紊乱治疗市场分析：副产品

• 概述（按产品）
• 按产品分类的历史和预测资料分析
• 精胺酸
• 甜菜碱
• 卡尔格酸
• 叶酸
• 沙丙蝶呤二盐酸盐
• 硫胺素
• 维生素 B6 和 B12
• 维生素D

第 7 章：全球胺基酸代谢紊乱治疗市场分析：按分销管道

• 配销通路概览
• 按配销通路进行历史和预测资料分析
• 医院药房
• 零售药局
• 网上商店

第 8 章：全球胺基酸代谢紊乱治疗市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区按国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲按国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：胺基酸代谢紊乱治疗公司的竞争格局

• 胺基酸代谢紊乱治疗市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Amino GmbH
• 公司概况
• 公司收入
• 产品
• 最新动态
• Civentichem LLC
• 公司概况
• 公司收入
• 产品
• 最新动态
• Koninklijke DSM NV
• 公司概况
• 公司收入
• 产品
• 最新动态
• Kyowa Hakko Kirin Co. Ltd
• 公司概况
• 公司收入
• 产品
• 最新动态
• Merck KGaA And Recordati SPA
• 公司概况
• 公司收入
• 产品
• 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

The global demand for Amino Acid Metabolism Disorders Treatment Market is presumed to reach the market size of nearly USD 1101.11 Million by 2032 from USD 715.29 Million in 2023 with a CAGR of 4.91% under the study period 2024-2032.

Amino acid metabolism disorders are inherited metabolic diseases that usually manifest in childhood. These disorders affect the metabolism of amino acids such as phenylketonuria, tyrosinemia, homocystinuria, and non-ketotic hyperglycinemia among others. These disorders are autosomal recessive, and can be diagnosed by analyzing amino acid concentrations in body fluids. Amino acid metabolism disorders treatments may include special diets, medicines, and few supplements. Blood tests, dialysis and transplants are some of the amino acid metabolism disorders treatment.

MARKET DYNAMICS

In the future, the global amino acid metabolism disorders treatment market is predicted to rise due to the rising prevalence of amino acid metabolism disorders such as phenylketonuria and maple syrup urine. The expansion of the amino acid metabolism disorder therapy market would be slowed in the forthcoming years due to rising costs of amino acid supplements and patient non-compliance. Familial hypercholesterolemia, Gaucher disease, Hunter syndrome, Krabbe disease, Metachromatic leukodystrophy, Mitochondrial encephalopathy, lactic acidosis, stroke-like episodes (MELAS), and Niemann-Pick disease are expected to be significant growth drivers for the amino acid metabolism disorders treatment market over the forecast period. Again, the rising prevalence of chronic diseases necessitates more effective treatment management to enhance patient outcomes. As a result, the amino acid metabolism disorders therapy market is expected to increase significantly throughout the forecast period.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Amino Acid Metabolism Disorders Treatment. The growth and trends of Amino Acid Metabolism Disorders Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Amino Acid Metabolism Disorders Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Indication

• Argininosuccinic Academia
• Citrullinemia
• Homocystinuria
• Phenylketonuria
• Maple Syrup Urine Disease

By Product

• Arginine
• Betaine
• Carglumic Acid
• Folic Acid
• Sapropterin Dihydrochloride
• Thiamine
• Vitamin B6 and B12
• Vitamin D

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Stores

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Amino Acid Metabolism Disorders Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Amino Acid Metabolism Disorders Treatment market include Amino GmbH, Civentichem LLC, Koninklijke DSM N.V., Kyowa Hakko Kirin Co. Ltd, Merck KGaA And Recordati S.P.A. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. AMINO ACID METABOLISM DISORDERS TREATMENT - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Indication
  • 3.7.2 Market Attractiveness Analysis By Product
  • 3.7.3 Market Attractiveness Analysis By Distribution Channel
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET ANALYSIS BY INDICATION

• 5.1. Overview By Indication
• 5.2. Historical and Forecast Data Analysis By Indication
• 5.3. Argininosuccinic Academia Historic and Forecast Sales By Regions
• 5.4. Citrullinemia Historic and Forecast Sales By Regions
• 5.5. Homocystinuria Historic and Forecast Sales By Regions
• 5.6. Phenylketonuria Historic and Forecast Sales By Regions
• 5.7. Maple Syrup Urine Disease Historic and Forecast Sales By Regions

6. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET ANALYSIS BY PRODUCT

• 6.1. Overview By Product
• 6.2. Historical and Forecast Data Analysis By Product
• 6.3. Arginine Historic and Forecast Sales By Regions
• 6.4. Betaine Historic and Forecast Sales By Regions
• 6.5. Carglumic Acid Historic and Forecast Sales By Regions
• 6.6. Folic Acid Historic and Forecast Sales By Regions
• 6.7. Sapropterin Dihydrochloride Historic and Forecast Sales By Regions
• 6.8. Thiamine Historic and Forecast Sales By Regions
• 6.9. Vitamin B6 and B12 Historic and Forecast Sales By Regions
• 6.10. Vitamin D Historic and Forecast Sales By Regions

7. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 7.1. Overview By Distribution Channel
• 7.2. Historical and Forecast Data Analysis By Distribution Channel
• 7.3. Hospital Pharmacies Historic and Forecast Sales By Regions
• 7.4. Retail Pharmacies Historic and Forecast Sales By Regions
• 7.5. Online Stores Historic and Forecast Sales By Regions

8. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE AMINO ACID METABOLISM DISORDERS TREATMENT COMPANIES

• 9.1. Amino Acid Metabolism Disorders Treatment Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF AMINO ACID METABOLISM DISORDERS TREATMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Amino GmbH
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Civentichem LLC
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Koninklijke DSM N.V.
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Kyowa Hakko Kirin Co. Ltd
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Merck KGaA And Recordati S.P.A
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Indication (USD MN)
• Argininosuccinic Academia Market Sales By Geography (USD MN)
• Citrullinemia Market Sales By Geography (USD MN)
• Homocystinuria Market Sales By Geography (USD MN)
• Phenylketonuria Market Sales By Geography (USD MN)
• Maple Syrup Urine Disease Market Sales By Geography (USD MN)
• Analysis By Product (USD MN)
• Arginine Market Sales By Geography (USD MN)
• Betaine Market Sales By Geography (USD MN)
• Carglumic Acid Market Sales By Geography (USD MN)
• Folic Acid Market Sales By Geography (USD MN)
• Sapropterin Dihydrochloride Market Sales By Geography (USD MN)
• Thiamine Market Sales By Geography (USD MN)
• Vitamin B6 and B12 Market Sales By Geography (USD MN)
• Vitamin D Market Sales By Geography (USD MN)
• Analysis By Distribution Channel (USD MN)
• Hospital Pharmacies Market Sales By Geography (USD MN)
• Retail Pharmacies Market Sales By Geography (USD MN)
• Online Stores Market Sales By Geography (USD MN)
• Global Amino Acid Metabolism Disorders Treatment Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Amino Acid Metabolism Disorders Treatment Report
• Market Research Process
• Market Research Methodology
• Global Amino Acid Metabolism Disorders Treatment Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Indication
• Market Attractiveness Analysis By Product
• Market Attractiveness Analysis By Distribution Channel
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Indication (USD MN)
• Argininosuccinic Academia Market Sales By Geography (USD MN)
• Citrullinemia Market Sales By Geography (USD MN)
• Homocystinuria Market Sales By Geography (USD MN)
• Phenylketonuria Market Sales By Geography (USD MN)
• Maple Syrup Urine Disease Market Sales By Geography (USD MN)
• Global Market Analysis By Product (USD MN)
• Arginine Market Sales By Geography (USD MN)
• Betaine Market Sales By Geography (USD MN)
• Carglumic Acid Market Sales By Geography (USD MN)
• Folic Acid Market Sales By Geography (USD MN)
• Sapropterin Dihydrochloride Market Sales By Geography (USD MN)
• Thiamine Market Sales By Geography (USD MN)
• Vitamin B6 and B12 Market Sales By Geography (USD MN)
• Vitamin D Market Sales By Geography (USD MN)
• Global Market Analysis By Distribution Channel (USD MN)
• Hospital Pharmacies Market Sales By Geography (USD MN)
• Retail Pharmacies Market Sales By Geography (USD MN)
• Online Stores Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.